Literature DB >> 27763987

Insomnia and the Risk of Breast Cancer: The HUNT Study.

Abhijit Sen1, Signe Opdahl, Linn Beate Strand, Lars Johan Vatten, Lars Erik Laugsand, Imre Janszky.   

Abstract

OBJECTIVE: The association of insomnia with subsequent breast cancer risk is largely unknown. Therefore, we assessed whether different symptoms of insomnia and their combination are associated with incident breast cancer in a large population-based study.
METHODS: In a prospective cohort study, 33,332 women were followed to monitor the occurrence of their first invasive breast cancer identified by the Cancer Registry of Norway. Insomnia symptoms including () nonrestorative sleep and () difficulty initiating and () maintaining sleep were self-reported using a study specific measure reflecting the current Diagnostic and Statistical Manual of Mental Disorders criteria. Hazard ratios and 95% confidence intervals were calculated using multiadjusted Cox proportional hazards models.
RESULTS: A total of 862 incident breast cancer cases occurred during a mean follow-up of 14.7 years. No consistent association was observed between the individual insomnia symptoms and breast cancer risk. However, compared to women reporting no insomnia complaints, those who reported having all three aspects of insomnia simultaneously were at increased risk (hazard ratio, 2.38; 95% confidence interval = 1.11-5.09).
CONCLUSION: Our results suggest that having only some aspects of insomnia may not predispose someone to breast cancer. In contrast, experiencing all insomnia symptoms simultaneously might confer considerable excess risk.

Entities:  

Mesh:

Year:  2017        PMID: 27763987     DOI: 10.1097/PSY.0000000000000417

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  7 in total

1.  Fall Risk, Healthcare Resource Use, and Costs Among Adult Patients in the United States Treated for Insomnia with Zolpidem, Trazodone, or Benzodiazepines: A Retrospective Cohort Study.

Authors:  Diana T Amari; Timothy R Juday; Feride H Frech; Weiying Wang; Deval Gor; Norman Atkins; Emerson M Wickwire
Journal:  Adv Ther       Date:  2022-01-24       Impact factor: 3.845

2.  Sleep quality and risk of cancer: findings from the English longitudinal study of aging.

Authors:  Chenxi Song; Rui Zhang; Chunyue Wang; Rui Fu; Weihua Song; Kefei Dou; Shuang Wang
Journal:  Sleep       Date:  2021-03-12       Impact factor: 5.849

3.  Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study.

Authors:  Rebecca C Richmond; Emma L Anderson; Hassan S Dashti; Samuel E Jones; Jacqueline M Lane; Linn Beate Strand; Ben Brumpton; Martin K Rutter; Andrew R Wood; Kurt Straif; Caroline L Relton; Marcus Munafò; Timothy M Frayling; Richard M Martin; Richa Saxena; Michael N Weedon; Debbie A Lawlor; George Davey Smith
Journal:  BMJ       Date:  2019-06-26

4.  Depressive Symptoms, Sleep Profiles and Serum Melatonin Levels in a Sample of Breast Cancer Patients.

Authors:  Nevin Fw Zaki; Yomna M Sabri; Omar Farouk; Amany Abdelfatah; David Warren Spence; Ahmed S Bahammam; Seithikurippu R Pandi-Perumal
Journal:  Nat Sci Sleep       Date:  2020-02-13

5.  Association of Insomnia, Depressive Disorders, and Mood Disorders as Risk Factors With Breast Cancer: A Nationwide Population-Based Cohort Study of 232,108 Women in Taiwan.

Authors:  Hui-Pu Liu; James Cheng-Chung Wei; Hei-Tung Yip; Ming-Hsin Yeh
Journal:  Front Oncol       Date:  2021-10-11       Impact factor: 6.244

6.  Understanding insomnia as systemic disease.

Authors:  Seokho Yun; Sohye Jo
Journal:  Yeungnam Univ J Med       Date:  2021-09-13

Review 7.  The Association of Sleep Disorders, Obesity and Sleep-Related Hypoxia with Cancer.

Authors:  Anna Brzecka; Karolina Sarul; Tomasz Dyła; Marco Avila-Rodriguez; Ricardo Cabezas-Perez; Vladimir N Chubarev; Nina N Minyaeva; Sergey G Klochkov; Margarita E Neganova; Liudmila M Mikhaleva; Siva G Somasundaram; Cecil E Kirkland; Vadim V Tarasov; Gjumrakch Aliev
Journal:  Curr Genomics       Date:  2020-09       Impact factor: 2.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.